PER 34.1% 8.9¢ percheron therapeutics limited

licensing due diligence, page-6

  1. 2,843 Posts.
    Sid, you cant just throw in the majority of ramping statements that go on here.
    I was stating a range of things that could happen here with regards to funding so its not "shut up shop altogether" that i am implying.
    I am implying it could be CR, convertable note, partnership or worse case scenario funding not forthcoming and cannot proceed.
    Sid this is a speculative stock if you hadnt realise and far bigger companies than ANP have failed.
    Noone is saying that will happen, but a holder of these types of companies need to not only listen to pie in the sky ramping because many many scenarios could take place.
    Anyhow i stated the facts in the first paragraph as thet was what you were asking re timeframes.
    It never surprises me though how investors only want to hear what they want to hear.
    Cheers and no more from me on this topic.
    Cheers
    Rob
  2. This thread is closed.

    You may not reply to this discussion at this time.

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.